{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:05:40Z","timestamp":1771232740995,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ijcard.2012.10.011","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T01:15:16Z","timestamp":1352164516000},"page":"789-794","source":"Crossref","is-referenced-by-count":19,"title":["Effects of ivabradine in patients with stable angina receiving beta-blockers according to baseline heart rate: an analysis of the ASSOCIATE study"],"prefix":"10.1016","volume":"168","author":[{"given":"Jean-Claude","family":"Tardif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2012.10.011_bb0080","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1056\/NEJMoa043012","article-title":"Heart-rate profile during exercise as a predictor of sudden death","volume":"352","author":"Jouven","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0085","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0735-1097(92)90363-R","article-title":"Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease","volume":"20","author":"Panza","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0090","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0735-1097(01)01451-6","article-title":"Changes in heart rate and heart rate variability before ambulatory ischemic events(1)","volume":"38","author":"Kop","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/01.CIR.88.1.92","article-title":"Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS)","volume":"88","author":"Andrews","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0735-1097(02)02848-6","volume":"41","author":"Gibbons","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0105","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2165\/00003495-200464160-00003","article-title":"Heart rate lowering by specific and selective If current inhibition with ivabradine. A new therapeutic perspective in cardiovascular disease","volume":"64","author":"DiFrancesco","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.0000048143.25023.87","article-title":"Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial","volume":"107","author":"Borer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00003495-200767030-00005","article-title":"Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial","volume":"67","author":"Ruzyllo","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0120","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina","volume":"26","author":"Tardif","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0005","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/eurheartj\/ehp358","article-title":"Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial","volume":"30","author":"Fox","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4month, randomized, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0015","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"Bohm","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0020","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0025","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1476-5381.1996.tb15505.x","article-title":"Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells","volume":"118","author":"Bois","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MJT.0b013e3181758855","article-title":"Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor","volume":"15","author":"Borer","year":"2008","journal-title":"Am J Ther"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/pgmj.2009.084384","article-title":"Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey","volume":"86","author":"Daly","year":"2010","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0040","doi-asserted-by":"crossref","first-page":"e36284","DOI":"10.1371\/journal.pone.0036284","article-title":"Heart rate and use of beta-blockers in stable outpatients with coronary artery disease","volume":"7","author":"Steg","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0045","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10557-011-6327-3","article-title":"Efficacy of ivabradine in combination with beta-blocker versus uptitration of beta-blocker in patients with stable angina","volume":"25","author":"Amosova","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00002018-200831020-00001","article-title":"I(f) inhibition with ivabradine : electrophysiological effects and safety","volume":"31","author":"Savelieva","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2010.10.065","article-title":"Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy)","volume":"107","author":"Tendera","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0130","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology","volume":"27","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2012.10.011_bb0070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/eurheartj\/ehi705","article-title":"Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction","volume":"27","author":"Gislason","year":"2006","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2012.10.011_bb0075","first-page":"198","article-title":"Ivabradine improves exercise capacity in patients with stable angina pectoris receiving maximal tolerated dose of beta-blockers: a subgroups analysis of the ASSOCIATE study. P1335","volume":"31","author":"Tardif","year":"2010","journal-title":"Eur Heart J"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731201385X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731201385X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T08:34:14Z","timestamp":1562315654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731201385X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S016752731201385X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2012.10.011","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}